Related Experiment Video
Updated: May 13, 2026

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
Published on: January 10, 2025
An equivalence test for the comparison between a test drug and placebo in human abuse potential studies
Ling Chen1, Katherine R Bonson
1Division of Biometrics VI, Office of Biostatistics, Office of Translational Sciences, Center for Drug Evaluation and Research , U.S. Food and Drug Administration , Silver Spring , MD 20903 , USA. ling.chen@fda.hhs.gov
Abstract:
Statistical methodologies for human abuse potential studies are rarely evaluated. Human abuse potential studies assess whether test drugs produce positive and negative subjective responses on abuse-related measures using volunteers with histories of recreational drug use. These studies typically have a randomized, double-blind, placebo- and positive-controlled crossover design with at least four treatments: placebo, at least two doses of a test drug, and at least one dose of a positive control drug (a drug with known abuse potential). This article proposes a new test for assessing whether a test drug produces data indicative of abuse potential when compared to placebo.
Related Concept Videos
Bioequivalence of Drugs: Drugs with Multiple Indications
Toxicity Testing in Animals
Bioequivalence studies: Biowaivers
Equivalence: In Vitro and In Vivo Bioequivalence
Bioequivalence Data: Statistical Interpretation
Bioequivalence: Overview

